Arexvy
respiratory syncytial virus (rsv) vaccine (recombinant, adjuvanted)
Centralised EU authorisationActive
Marketing holder: GlaxoSmithKline Biologicals S.A.
Verified 2026-10-09 · EMA
- Source: EMA
Composition
- respiratory syncytial virus (rsv) vaccine (recombinant, adjuvanted)
Registration
- Registration number
- EMEA/H/C/006054
- Registration status
- Active
- ATC code
- J07BX05
Sources
- product · EMA · EMEA/H/C/006054 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/006054 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/006054 · Verified 2026-10-09